Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
Sale
Calculated transaction value
$93.96K
2,035 shares @ $46.17
Traded
Nov 3, 2026
Filed
Nov 3, 2026
You're reading the free version. Trader adds the live tape and alerts.
Start tracking
Alkermes Inc
ALKS
ManufacturingChemicals
Transactions reported in official disclosures
Price with disclosed trades
Daily closes, past year · marks sit on transaction dates, sized by value
43 trades
| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Nov 3, 2026 Same-day filing | Sale Nov 3, 2026 | $93.96K Filed shares x price | SEC Form 4 View filing | |
| Hon. Gilbert Cisneros U.S. House member | Oct 12, 2026 13-day lag | Buy Sep 29, 2026 | $1K - $15K Reported range | House PTR View filing | |
| Reed Joshua SVP, Chief Financial Officer | Oct 9, 2026 1-day lag | Exercise Oct 8, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Reed Joshua SVP, Chief Financial Officer | Oct 9, 2026 1-day lag | Disposition Oct 8, 2026 | $163.21K Filed shares x price | SEC Form 4 View filing | |
| Reed Joshua SVP, Chief Financial Officer | Oct 9, 2026 1-day lag | Exercise Oct 8, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Whitaker Anne Clem Director | Oct 9, 2026 2-day lag | Award Oct 7, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Whitaker Anne Clem Director | Oct 9, 2026 2-day lag | Award Oct 7, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Oct 2, 2026 Same-day filing | Sale Oct 2, 2026 | $83.46K Filed shares x price | SEC Form 4 View filing | |
| Donald J Trump Executive branch official | Sep 22, 2026 55-day lag | Sale Jul 29, 2026 | $50K - $100K Reported range | OGE 278-T View filing | |
| Hon. Gilbert Cisneros U.S. House member | Sep 4, 2026 36-day lag | Buy Jul 30, 2026 | $15K - $50K Reported range | House PTR View filing | |
| Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Sep 3, 2026 Same-day filing | Sale Sep 3, 2026 | $97.65K Filed shares x price | SEC Form 4 View filing | |
| Hopkinson Craig C. EVP R&d, Chief Medical Officer | Sep 1, 2026 Same-day filing | Exercise Sep 1, 2026 | $122.95K Filed shares x price | SEC Form 4 View filing | |
| Hopkinson Craig C. EVP R&d, Chief Medical Officer | Sep 1, 2026 Same-day filing | Sale Sep 1, 2026 | $422.87K Filed shares x price | SEC Form 4 View filing | |
| Hopkinson Craig C. EVP R&d, Chief Medical Officer | Sep 1, 2026 Same-day filing | Exercise Sep 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Donald J Trump Executive branch official | Aug 22, 2026 68-day lag | Buy Jun 15, 2026 | $1K - $15K Reported range | OGE 278-T View filing | |
| Nichols Christian Todd SVP, Chief Commercial Officer | Aug 17, 2026 Same-day filing | Sale Aug 17, 2026 | $339.97K Filed shares x price | SEC Form 4 View filing | |
| Nichols Christian Todd SVP, Chief Commercial Officer | Aug 17, 2026 Same-day filing | Sale Aug 17, 2026 | $32.97K Filed shares x price | SEC Form 4 View filing | |
| Jackson Blair Curtis President & CEO, Alkermes PLC | Aug 7, 2026 2-day lag | Award Aug 5, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Jackson Blair Curtis President & CEO, Alkermes PLC | Aug 7, 2026 2-day lag | Award Aug 5, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Snyderman Nancy Lynn Md Director | Aug 3, 2026 Same-day filing | Exercise Aug 3, 2026 | $772K Filed shares x price | SEC Form 4 View filing | |
| Snyderman Nancy Lynn Md Director | Aug 3, 2026 Same-day filing | Sale Aug 3, 2026 | $2.24M Filed shares x price | SEC Form 4 View filing | |
| Snyderman Nancy Lynn Md Director | Aug 3, 2026 Same-day filing | Exercise Aug 3, 2026 | $1.31M Filed shares x price | SEC Form 4 View filing | |
| Snyderman Nancy Lynn Md Director | Aug 3, 2026 Same-day filing | Exercise Aug 3, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Snyderman Nancy Lynn Md Director | Aug 3, 2026 Same-day filing | Exercise Aug 3, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | Aug 3, 2026 Same-day filing | Exercise Aug 3, 2026 | $120.39K Filed shares x price | SEC Form 4 View filing | |
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | Aug 3, 2026 Same-day filing | Exercise Aug 3, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | Aug 3, 2026 Same-day filing | Exercise Aug 3, 2026 | $2.01K Filed shares x price | SEC Form 4 View filing | |
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | Aug 3, 2026 Same-day filing | Sale Aug 3, 2026 | $437.22K Filed shares x price | SEC Form 4 View filing | |
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | Aug 3, 2026 Same-day filing | Exercise Aug 3, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Aug 3, 2026 Same-day filing | Sale Aug 3, 2026 | $98.81K Filed shares x price | SEC Form 4 View filing |
Hon. Gilbert Cisneros
U.S. House member
Buy
Reported value range
$1K - $15K
Not reported
Traded
Sep 29, 2026
Filed
Oct 12, 2026
Reed Joshua
SVP, Chief Financial Officer
Exercise
Reported value range
Not reported
9,164 shares
Traded
Oct 8, 2026
Filed
Oct 9, 2026
Reed Joshua
SVP, Chief Financial Officer
Disposition
Calculated transaction value
$163.21K
4,069 shares @ $40.11
Traded
Oct 8, 2026
Filed
Oct 9, 2026
Reed Joshua
SVP, Chief Financial Officer
Exercise
Reported value range
Not reported
9,164 shares
Traded
Oct 8, 2026
Filed
Oct 9, 2026
Whitaker Anne Clem
Director
Award
Calculated transaction value
$0
7,239 shares @ $0
Traded
Oct 7, 2026
Filed
Oct 9, 2026
Whitaker Anne Clem
Director
Award
Calculated transaction value
$0
17,998 shares @ $0
Traded
Oct 7, 2026
Filed
Oct 9, 2026
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
Sale
Calculated transaction value
$83.46K
2,034 shares @ $41.03
Traded
Oct 2, 2026
Filed
Oct 2, 2026
Donald J Trump
Executive branch official
Sale
Reported value range
$50K - $100K
Not reported
Traded
Jul 29, 2026
Filed
Sep 22, 2026
Hon. Gilbert Cisneros
U.S. House member
Buy
Reported value range
$15K - $50K
Not reported
Traded
Jul 30, 2026
Filed
Sep 4, 2026
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
Sale
Calculated transaction value
$97.65K
2,034 shares @ $48.01
Traded
Sep 3, 2026
Filed
Sep 3, 2026
Hopkinson Craig C.
EVP R&d, Chief Medical Officer
Exercise
Calculated transaction value
$122.95K
5,000 shares @ $24.59
Traded
Sep 1, 2026
Filed
Sep 1, 2026
Hopkinson Craig C.
EVP R&d, Chief Medical Officer
Sale
Calculated transaction value
$422.87K
9,000 shares @ $46.99
Traded
Sep 1, 2026
Filed
Sep 1, 2026
Hopkinson Craig C.
EVP R&d, Chief Medical Officer
Exercise
Calculated transaction value
$0
5,000 shares @ $0
Traded
Sep 1, 2026
Filed
Sep 1, 2026
Donald J Trump
Executive branch official
Buy
Reported value range
$1K - $15K
Not reported
Traded
Jun 15, 2026
Filed
Aug 22, 2026
Nichols Christian Todd
SVP, Chief Commercial Officer
Sale
Calculated transaction value
$339.97K
6,912 shares @ $49.19
Traded
Aug 17, 2026
Filed
Aug 17, 2026
Nichols Christian Todd
SVP, Chief Commercial Officer
Sale
Calculated transaction value
$32.97K
664 shares @ $49.65
Traded
Aug 17, 2026
Filed
Aug 17, 2026
Jackson Blair Curtis
President & CEO, Alkermes PLC
Award
Calculated transaction value
$0
93,229 shares @ $0
Traded
Aug 5, 2026
Filed
Aug 7, 2026
Jackson Blair Curtis
President & CEO, Alkermes PLC
Award
Calculated transaction value
$0
124,305 shares @ $0
Traded
Aug 5, 2026
Filed
Aug 7, 2026
Snyderman Nancy Lynn Md
Director
Exercise
Calculated transaction value
$772K
16,524 shares @ $46.72
Traded
Aug 3, 2026
Filed
Aug 3, 2026
Snyderman Nancy Lynn Md
Director
Sale
Calculated transaction value
$2.24M
44,472 shares @ $50.35
Traded
Aug 3, 2026
Filed
Aug 3, 2026
Snyderman Nancy Lynn Md
Director
Exercise
Calculated transaction value
$1.31M
27,948 shares @ $46.72
Traded
Aug 3, 2026
Filed
Aug 3, 2026
Snyderman Nancy Lynn Md
Director
Exercise
Calculated transaction value
$0
16,524 shares @ $0
Traded
Aug 3, 2026
Filed
Aug 3, 2026
Snyderman Nancy Lynn Md
Director
Exercise
Calculated transaction value
$0
27,948 shares @ $0
Traded
Aug 3, 2026
Filed
Aug 3, 2026
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Exercise
Calculated transaction value
$120.39K
4,896 shares @ $24.59
Traded
Aug 3, 2026
Filed
Aug 3, 2026
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Exercise
Calculated transaction value
$0
104 shares @ $0
Traded
Aug 3, 2026
Filed
Aug 3, 2026
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Exercise
Calculated transaction value
$2.01K
104 shares @ $19.34
Traded
Aug 3, 2026
Filed
Aug 3, 2026
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Sale
Calculated transaction value
$437.22K
9,000 shares @ $48.58
Traded
Aug 3, 2026
Filed
Aug 3, 2026
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Exercise
Calculated transaction value
$0
4,896 shares @ $0
Traded
Aug 3, 2026
Filed
Aug 3, 2026
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
Sale
Calculated transaction value
$98.81K
2,034 shares @ $48.58
Traded
Aug 3, 2026
Filed
Aug 3, 2026